source name	assay name	Technology Type	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[biological replicate]	characteristics[individual]	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	factor value[disease]
Sample 1	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	1	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	2	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	3	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	4	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	5	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	6	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	7	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	8	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	9	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 1	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	10	PXD018357	20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F1_20200318175539.raw	1	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	11	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	12	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	13	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	14	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	15	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	16	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	17	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	18	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	19	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 2	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	20	PXD018357	20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F2_20200318195837.raw	2	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	21	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	22	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	23	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	24	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	25	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	26	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	27	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	28	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	29	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 3	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	30	PXD018357	20200317_KKL_CoV2_24h_5v5_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F3.raw	3	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	31	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	32	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	33	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	34	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	35	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	36	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	37	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	38	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	39	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 4	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	40	PXD018357	20200317_KKL_CoV2_24h_5v5_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F4.raw	4	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	41	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	42	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	43	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	44	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	45	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	46	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	47	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	48	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	49	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 5	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	50	PXD018357	20200317_KKL_CoV2_24h_5v5_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F5.raw	5	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	51	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	52	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	53	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	54	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	55	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	56	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	57	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	58	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	59	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 6	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	60	PXD018357	20200317_KKL_CoV2_24h_5v5_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F6.raw	6	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	61	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	62	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	63	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	64	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	65	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	66	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	67	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	68	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	69	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 7	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	70	PXD018357	20200317_KKL_CoV2_24h_5v5_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F7.raw	7	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	71	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	72	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	73	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	74	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	75	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	76	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	77	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	78	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	79	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 8	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	80	PXD018357	20200317_KKL_CoV2_24h_5v5_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F8.raw	8	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	81	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	82	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	83	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	84	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	85	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	86	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	87	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	88	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	89	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 9	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	90	PXD018357	20200317_KKL_CoV2_24h_5v5_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F9.raw	9	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	91	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	92	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	93	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	94	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	95	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	96	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	97	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	98	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	99	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 10	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	100	PXD018357	20200317_KKL_CoV2_24h_5v5_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F10.raw	10	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	101	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	102	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	103	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	104	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	105	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	106	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	107	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	108	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	109	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 11	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	110	PXD018357	20200317_KKL_CoV2_24h_5v5_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F11.raw	11	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	111	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	112	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	113	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	114	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	115	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	116	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	117	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	118	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	119	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 12	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	120	PXD018357	20200317_KKL_CoV2_24h_5v5_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F12.raw	12	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	121	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	122	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	123	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	124	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	125	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	126	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	127	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	128	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	129	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 13	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	130	PXD018357	20200317_KKL_CoV2_24h_5v5_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F13.raw	13	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	131	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	132	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	133	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	134	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	135	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	136	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	137	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	138	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	139	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 14	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	140	PXD018357	20200317_KKL_CoV2_24h_5v5_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F14.raw	14	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	141	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	142	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	143	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	144	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	145	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	146	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	147	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	148	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	149	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 15	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	150	PXD018357	20200317_KKL_CoV2_24h_5v5_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F15.raw	15	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	151	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	152	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	153	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	154	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	155	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	156	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	157	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	158	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	159	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 16	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	160	PXD018357	20200317_KKL_CoV2_24h_5v5_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F16.raw	16	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	161	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	162	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	163	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	164	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	165	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	166	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	167	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	168	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	169	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 17	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	170	PXD018357	20200317_KKL_CoV2_24h_5v5_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F17.raw	17	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	171	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	172	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	173	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	174	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	175	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	176	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	177	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	178	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	179	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 18	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	180	PXD018357	20200317_KKL_CoV2_24h_5v5_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F18.raw	18	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	181	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	182	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	183	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	184	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	185	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	186	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	187	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	188	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	189	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 19	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	190	PXD018357	20200317_KKL_CoV2_24h_5v5_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F19.raw	19	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	191	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	192	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	193	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	194	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	195	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	196	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	197	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	198	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	199	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 20	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	200	PXD018357	20200317_KKL_CoV2_24h_5v5_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F20.raw	20	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	201	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	202	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	203	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	204	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	205	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	206	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	207	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	208	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	209	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 21	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	210	PXD018357	20200317_KKL_CoV2_24h_5v5_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F21.raw	21	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	211	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	212	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	213	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	214	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	215	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	216	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	217	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	218	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	219	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 22	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	220	PXD018357	20200317_KKL_CoV2_24h_5v5_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F22.raw	22	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	221	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	222	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	223	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	224	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	225	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	226	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	227	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	228	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	229	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 23	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	230	PXD018357	20200317_KKL_CoV2_24h_5v5_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F23.raw	23	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 1	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	1	231	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	0.5 Da	20 ppm	1	Control
Sample 2	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	2	232	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	0.5 Da	20 ppm	1	Control
Sample 3	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	3	233	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	0.5 Da	20 ppm	1	Control
Sample 4	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	4	234	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	0.5 Da	20 ppm	1	Control
Sample 5	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	Control	not available	5	235	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	0.5 Da	20 ppm	1	Control
Sample 6	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	1	236	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 7	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	2	237	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 8	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	3	238	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 9	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	4	239	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	0.5 Da	20 ppm	1	SARS-Cov2_infected
Sample 10	run 24	proteomic profiling by mass spectrometry	homo sapiens	Caco-2 cells	not available	not available	not available	not available	SARS-Cov2_infected	not available	5	240	PXD018357	20200317_KKL_CoV2_24h_5v5_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD018357/20200317_KKL_CoV2_24h_5v5_F24.raw	24	AC=MS:1002732;NT=Orbitrap Fusion Lumos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed		NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Met-loss;MT=Variable;PP=Protein N-term;AC=UNIMOD:765	NT=Met-loss+Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:766	NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	0.5 Da	20 ppm	1	SARS-Cov2_infected
